BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 8225473)

  • 1. 32P-postlabelling analysis of bulky aromatic adducts.
    Gupta RC
    IARC Sci Publ; 1993; (124):11-23. PubMed ID: 8225473
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 32P-postlabelling analysis of small aromatic and of bulky non-aromatic DNA adducts.
    Reddy MV
    IARC Sci Publ; 1993; (124):25-34. PubMed ID: 8225492
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An improved 32P-postlabelling assay for detection and quantitation of styrene 7,8-oxide-DNA adducts.
    Cantoreggi S; Gupta RC; Lutz WK
    IARC Sci Publ; 1993; (124):201-5. PubMed ID: 8225485
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 32P-Post-labelling method improvements for aromatic compound-related molecular epidemiology studies.
    Munnia A; Saletta F; Allione A; Piro S; Confortini M; Matullo G; Peluso M
    Mutagenesis; 2007 Nov; 22(6):381-5. PubMed ID: 17716983
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recovery of bulky DNA adducts by the regular and a modified 32P-postlabelling assay; influence of the DNA-isolation method.
    Kovács K; Anna L; Rudnai P; Schoket B
    Mutat Res; 2011 Mar; 721(1):95-100. PubMed ID: 21237286
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combined micropreparative techniques with synchronous fluorescence spectroscopy or 32P-postlabelling assay for carcinogen-DNA adduct determination.
    Shields PG; Kato S; Bowman ED; Petruzzelli S; Cooper DP; Povey AC; Weston A
    IARC Sci Publ; 1993; (124):243-54. PubMed ID: 8225491
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improvements in the 32P-postlabelling procedure to quantify bulky aromatic DNA adducts.
    Steenwinkel MJ; Roggeband R; van Delft JH; Baan RA
    IARC Sci Publ; 1993; (124):65-70. PubMed ID: 7693587
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 32P-postlabelling methods for cyclic DNA adducts.
    Watson WP; Crane AE; Steiner S
    IARC Sci Publ; 1993; (124):255-62. PubMed ID: 8225493
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 32P-postlabelling and mass spectrometric methods for analysis of bulky, polyaromatic carcinogen-DNA adducts in humans.
    Talaska G; Roh JH; Getek T
    J Chromatogr; 1992 Sep; 580(1-2):293-323. PubMed ID: 1400827
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improved thin-layer chromatographic separation of 32P-postlabeled DNA adducts.
    Spencer GG; Beach AC; Gupta RC
    J Chromatogr; 1993 Feb; 612(2):295-301. PubMed ID: 8468388
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhanced sensitivity of 32P-postlabeling analysis of aromatic carcinogen:DNA adducts.
    Gupta RC
    Cancer Res; 1985 Nov; 45(11 Pt 2):5656-62. PubMed ID: 4053037
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of DNA adducts in smokers' lung and urothelium by 32P-postlabelling: metabolic phenotype dependence and comparisons with other exposure markers.
    Bartsch H; Castegnaro M; Camus AM; Schouft A; Geneste O; Rojas M; Alexandrov K
    IARC Sci Publ; 1993; (124):331-40. PubMed ID: 8225503
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DNA adducts in tumour, normal peripheral lung and bronchus, and peripheral blood lymphocytes from smoking and non-smoking lung cancer patients: correlations between tissues and detection by 32P-postlabelling and immunoassay.
    Gyorffy E; Anna L; Gyori Z; Segesdi J; Minárovits J; Soltész I; Kostic S; Csekeo A; Poirier MC; Schoket B
    Carcinogenesis; 2004 Jul; 25(7):1201-9. PubMed ID: 15001535
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biochemical (postlabelling) methods for analysis of carcinogen-DNA adducts.
    Randerath K; Randerath E; Agrawal HP; Reddy MV
    IARC Sci Publ; 1984; (59):217-31. PubMed ID: 6443609
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The 32P-postlabeling assay for DNA adducts.
    Phillips DH; Arlt VM
    Nat Protoc; 2007; 2(11):2772-81. PubMed ID: 18007613
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of polycyclic aromatic hydrocarbon-DNA adducts by postlabelling with the weak beta-emitters 35S-phosphorothioate and 33P-phosphate, immobilized boronate chromatography and high-performance liquid chromatography.
    Baird WM; Lau HH; Schmerold I; Coffing SL; Brozich SL; Lee H; Harvey RG
    IARC Sci Publ; 1993; (124):217-26. PubMed ID: 8225488
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of DNA base damage by 32P-postlabelling: TLC separation of 5'-deoxynucleoside monophosphates.
    Hollstein M; Nair J; Bartsch H; Bochner B; Ames BN
    IARC Sci Publ; 1986; (70):437-48. PubMed ID: 3793190
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 32-P-HPLC analysis of DNA adducts formed in vitro and in vivo by 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine and 2-amino-3,4,8-trimethyl-3H-imidazo[4,5-f]quinoxaline, utilizing an improved adduct enrichment procedure.
    Wohlin P; Zeisig M; Gustafsson JA; Möller L
    Chem Res Toxicol; 1996 Sep; 9(6):1050-6. PubMed ID: 8870995
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of oxidative damage by 32P-postlabelling: 8-hydroxydeoxyguanosine as a marker of exposure.
    Povey AC; Wilson VL; Weston A; Doan VT; Wood ML; Essigmann JM; Shields PG
    IARC Sci Publ; 1993; (124):105-14. PubMed ID: 8225472
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 32P-postlabelling analysis of DNA-adducts formed by 4-(N-carbethoxy-N-nitrosamino)-(3-pyridyl)-1-butanone and 4-oxo-4-(3-pyridyl)- butanal.
    Schmeiser HH; Castonguay A; Wiessler M
    IARC Sci Publ; 1993; (124):207-10. PubMed ID: 8225486
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.